pMSCVpuroATT Citations (1)

Originally described in: Next-generation cDNA screening for oncogene and resistance phenotypes.
Shindoh N, Yoda A, Yoda Y, Sullivan TJ, Weigert O, Lane AA, Kopp N, Bird L, Rodig SJ, Fox EA, Weinstock DM PLoS One. 2012;7(11):e49201. doi: 10.1371/journal.pone.0049201. Epub 2012 Nov 7. PubMed Journal

---

Articles Citing pMSCVpuroATT

Articles
Expression of the preadipocyte marker ZFP423 is dysregulated between well-differentiated and dedifferentiated liposarcoma. Dang TN, Tiongco RP, Brown LM, Taylor JL, Lyons JM, Lau FH, Floyd ZE. BMC Cancer. 2022 Mar 21;22(1):300. doi: 10.1186/s12885-022-09379-6. PubMed

If you have published an article using this material, please email us at to have your article added to this page.